A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This is a Phase 2, double-blind, parallel-group, placebo-controlled study to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of multiple doses of ONO-2808 in patients with MSA. This is the first study of ONO-2808 in patients with MSA.
Epistemonikos ID: 10c49ead73979b89929941faf9912f5e8c9f4ef6
First added on: May 15, 2024